BioCapital Europe 2023

Richard Hausmann, CEO of Combinostics, will discuss our company history and development of the cNeuro® suite, our complete AI software solution that supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring. The platform includes the cMRI™ and cDSI™ applications, pending cPET™ application (WIP), industry-first Dementia Differential Analysis report, and clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy.